Target detection: Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 6, 2014, Pages 903-911

  Sonn, Geoffrey A ^a   Margolis, Daniel J ^b   Marks, Leonard S ^b  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biopsy; Magnetic resonance imaging; Prostatic neoplasms; Ultrasonography

Indexed keywords

BIOPSY GUN; BIOPSY TECHNIQUE; CANCER DIAGNOSIS; CANCER LOCALIZATION; HUMAN; IMAGE GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING-ULTRASOUND FUSION GUIDED PROSTATE BIOPSY; MAGNETIC RESONANCE IMAGING-ULTRASOUND FUSION-GUIDED PROSTATE BIOPSY DEVICE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE TUMOR; PROSTATECTOMY; REAL TIME ECHOGRAPHY; REVIEW; ROBOTICS; TRANSRECTAL ULTRASONOGRAPHY; ENDOSCOPIC ECHOGRAPHY; MALE; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

HUMANS; IMAGE-GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING; MALE; PROSTATE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84905278815     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.08.006     Document Type: Review

References (50)

1. Turnbull L.W., Buckley D.L., Turnbull L.S., Liney G.P., Knowles A.J. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology. J Magn Reson Imaging 1999, 9:311-316.
2. Loeb S., Carter H.B., Berndt S.I., Ricker W., Schaeffer E.M. Complications after prostate biopsy: data from SEER-Medicare. J Urol 2011, 186:1830-1834.
3. Cancer Facts & Figures. Cancerorg n.d.
4. Gibbs P., Tozer D.J., Liney G.P., Turnbull L.W. Comparison of quantitativeT2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 2001, 46:1054-1058.
5. Vallancien G., Leo J.P., Brisset J.M. Transperineal prostatic biopsy guided by transrectal ultrasonography. Prog Clin Biol Res 1987, 243B:25-27.
6. Hodge K.K., McNeal J.E., Terris M.K., Stamey T.A. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989, 142:71-74. [discussion74-5].
7. Turkbey B., Pinto P.A., Mani H., Bernardo M., Pang Y., McKinney Y.L., et al. Prostate Cancer: value of Multiparametric MR Imaging at 3T for Detection-histopathologic correlation. Radiology 2010, 255:89-99.
8. Presti J.C.J., O'Dowd G.J., Miller M.C., Mattu R., Veltri R.W. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 2003, 169:125-129.
9. Gore J.L., Shariat S.F., Miles B.J., Kadmon D., Jiang N., Wheeler T.M., et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 2001, 165:1554-1559.
10. Puech P., Potiron E., Lemaitre L., Leroy X., Haber G.-P., Crouzet S., et al. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. Urology 2009, 74:1094-1099.
11. Taira A.V., Merrick G.S., Galbreath R.W., Andreini H., Taubenslag W., Curtis R., et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis 2010, 13:71-77.
12. Fütterer J.J., Heijmink S.W., Scheenen T.W., Veltman J., Huisman H.J., Vos P., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006, 241:449-458.
13. Rouse P., Shaw G., Ahmed H.U., Freeman A., Allen C., Emberton M. Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study. Urol Int 2011, 87:49-53.
14. Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol 2013. Mar 17. doi:pii: S0302-2838(13)00249-2. [Epub ahead of print]. http://10.1016/j.eururo.2013.03.025.
15. Park B.K., Lee H.M., Kim C.K., Choi H.Y., Park J.W. Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy. Invest Radiol 2008, 43:789-793.
16. Simon J., Kuefer R., Bartsch G.J., Volkmer B.G., Hautmann R.E., Gottfried H.W. Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction. BJU Int 2008, 102:459-462.
17. Dickinson L., Ahmed H.U., Allen C., Barentsz J.O., Carey B., Fütterer J.J., et al. Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway?. J Magn Reson Imaging 2013, 37:48-58.
18. Ukimura O., Hung A.J., Gill I.S. Innovations in prostate biopsy strategies for active surveillance and focal therapy. Curr Opin Urol 2011, 21:115-120.
19. Barentsz J.O., Richenberg J., Clements R., Choyke P., Verma S., Villeirs G., et al. ESUR prostate MR guidelines 2012. Eur Radiol 2012, 22:746-757.
20. Toi A., Neill M.G., Lockwood G.A., Sweet J.M., Tammsalu L.A., Fleshner N.E. The continuing importance of transrectal ultrasound identification of prostatic lesions. J Urol 2007, 177:516-520.
21. Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Fütterer JJ, Gill IS, et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 2013.
22. Sciarra A., Barentsz J., Bjartell A., Eastham J., Hricak H., Panebianco V., et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol 2011, 59:962-977.
23. Hambrock T., Somford D.M., Huisman H.J., van Oort I.M., Witjes J.A., Hulsbergen-Van de Kaa C.A., et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 2011, 259:453-461.
24. Kasivisvanathan V., Dufour R., Moore C.M., Ahmed H.U., Abd-Alazeez M., Charman S.C., et al. Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. J Urol 2013, 189:860-866.
25. Hambrock T., Somford D.M., Hoeks C., Bouwense S.A., Huisman H., Yakar D., et al. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 2010, 183:520-527.
26. Pinto P.A., Chung P.H., Rastinehad A.R., Baccala A.A.J., Kruecker J., Benjamin C.J., et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol 2011, 186:1281-1285.
27. Hricak H., Williams R.D., Spring D.B., Moon K.L., Hedgcock M.W., Watson R.A., et al. Anatomy and pathology of the male pelvis by magnetic resonance imaging. AJR Am J Roentgenol 1983, 141:1101-1110.
28. Sonn G.A., Natarajan S., Margolis D.J.A., Macairan M., Lieu P., Huang J., et al. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. J Urol 2013, 189:86-91.
29. Hadaschik B.A., Kuru T.H., Tulea C., Rieker P., Popeneciu I.V., Simpfendorfer T., et al. A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. J Urol 2011, 186:2214-2220.
30. Moore C.M., Robertson N.L., Arsanious N., Middleton T., Villers A., Klotz L., et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 2013, 63:125-140.
31. Bezzi M., Kressel H.Y., Allen K.S., Schiebler M.L., Altman H.G., Wein A.J., et al. Prostatic carcinoma: staging with MR imaging at 1.5T. Radiology 1988, 169:339-346.
32. Perrotti M., Han K.R., Epstein R.E., Kennedy E.C., Rabbani F., Badani K., et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. J Urol 1999, 162:1314-1317.
33. D'Amico A.V., Tempany C.M., Cormack R., Hata N., Jinzaki M., Tuncali K., et al. Transperineal magnetic resonance image guided prostate biopsy. J Urol 2000, 164:385-387.
34. van Herk M., Bruce A., Kroes A.P., Shouman T., Touw A., Lebesque J.V. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys 1995, 33:1311-1320.
35. Deurloo K.E., Steenbakkers R.J., Zijp L.J., de Bois J.A., Nowak P.J., Rasch CR, et al. Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy. Int J Radiat Oncol Biol Phys 2005, 61:228-238.
36. Ghilezan M.J., Jaffray D.A., Siewerdsen J.H., van Herk M., Shetty A., Sharpe M.B., et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 2005, 62:406-417.
37. Baumann M., Mozer P., Daanen V., Troccaz J. Prostate biopsy tracking with deformation estimation. Med Image Anal 2012, 16:562-576.
38. Guo Y., Werahera P.N., Narayanan R. Image registration accuracy of a 3-dimensional transrectal ultrasound-guided prostate biopsy system. J Ultrasound Med 2009, 28:1561-1568.
39. Natarajan S., Marks L.S., Margolis D.J., Huang J., Macairan M.L., Lieu P., et al. Clinical application of a 3D ultrasound-guided prostate biopsy system. Urol Oncol 2011, 29:334-342.
40. Xu S., Kruecker J., Turkbey B., Glossop N., Singh A.K., Choyke P., et al. Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies. Comput Aided Surg 2008, 13:255-264.
41. Vourganti S., Rastinehad A., Yerram N.K., Nix J., Volkin D., Hoang A., et al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol 2012.
42. Baumann M, Mozer P, Daanen V, Troccaz J. Prostate biopsy assistance system with gland deformation estimation for enhanced precision. Lecture notes in computer science, 5761, Berlin, Heidelberg: Springer; 2009, pp. 67-74.
43. Portalez D., Mozer P., Cornud F., Renard-Penna R., Misrai V., Thoulouzan M., et al. Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol 2012, 62:986-996.
44. Delongchamps N.B., Peyromaure M., Schull A., Beuvon F., Bouazza N., Flam T., et al. Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol 2013, 189:493-499.
45. Puech P., Rouvière O., Renard-Penna R., Villers A., Devos P., Colombel M., et al. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy-Prospective multicenter study. Radiology 2013, 268:461-469.
46. Haffner J., Lemaitre L., Puech P., Haber G.-P., Leroy X., Jones J.S., et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int 2011, 108:E171-E178.
47. Robertson N.L., Hu Y., Ahmed H.U., Freeman A., Barratt D., Emberton M. Prostate cancer risk inflation as a consequence of image-targeted biopsy of the prostate: a computer simulation study. Eur Urol 2013, Jan 3, pii: S0302-2838(12)01587-4.
48. Carter H.B., Albertsen P.C., Barry M.J., Etzioni R., Freedland S.J., Greene K.L., et al. Early detection of prostate cancer: AUA guideline. J Urol 2013, 190:419-426.
49. Mowatt G., Scotland G., Boachie C. The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation. Health Technol 2013, 17:vii-xix. 1-281.
50. Marks L., Young S., Natarajan S. MRI-ultrasound fusion for guidance of targeted prostate biopsy. Curr Opin Urol 2013, 23:43-50.